Skip to main content
. 2020 Jul 4;21(13):4766. doi: 10.3390/ijms21134766
PD Parkinson’s Disease
α-Syn α-synuclein
ROT rotenone
PQ paraquat
MB maneb
ROS reactive oxygen species
H2O2 hydrogen peroxide
GSH Glutathione
BBB blood brain barrier
CNS central nervous system
ARs adenosine receptors
MAO-B monoamine oxidase-B
Nrf2 nuclear factor erythroid 2-related factor 2
PGC-1α peroxisome proliferator-activated receptor-gamma coactivator 1-α
KO knockout
PDE phosphodiesterase
A2AR adenosine 2A receptor
PKA protein kinase A
TNF-α tumor necrosis factor alpha
L-DOPA L-3,4-dihydroxyphenylalanine
GABA γ-aminobutyric acid
A1R adenosine 1 receptor
MPTP N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
6-OHDA 6-hydroxydopamine
qRT-PCR quantitative real-time polymerase chain reaction
DOPAC 3,4 dihydroxyphenylacetic acid
CSC 8-(-3-chlorostyryl)-caffeine
AIMs abnormal involuntary movements
THP trihexyphenidyl
ESS Epworth Sleepiness Scale
UPDRS unified Parkinson’s Disease rating scale
HC healthy control
HPFS Study of Health Professionals
NHS Nurses’ Health Study